You are here

Roche

Roche yields to cancer biosim competition by offering 'relevant' discounts: report

Fierce Pharma

Thu, 12/10/20 - 07:19 pm

Roche, Blueprint raise pressure on Lilly with new Gavreto approval

Pharmaforum

Wed, 12/2/20 - 10:33 am

Blueprint Medicines

Swiss start-up Noema raises $59m to develop neurology drugs offloaded by Roche

Pharmaforum

Wed, 12/2/20 - 10:29 am

neurological disorders

Roche shelved these psychiatry drugs. So its former head of neuro cooked up some new plans — and raised $59M for his startup

Endpoints

Tue, 12/1/20 - 10:46 am

FDA approves Roche’s Xofluza to prevent flu spreading in families

Pharmaforum

Tue, 11/24/20 - 10:26 am

The Week Ahead In Biotech: Moderna Vaccine And Roche, Revance, Rhythm, Liquidia FDA Updates

Yahoo/Benzinga

Sun, 11/22/20 - 11:53 pm

Moderna Therapeutics

Rhythm Pharmaceuticals

Samsung Biologics, AstraZeneca to dissolve biosimilar JV, scrap Rituxan copy program: report

Fierce Pharma

Thu, 11/19/20 - 08:29 pm

Samsung BioLogics

Archigen Biotech

Roche, Lead Pharma partner to develop oral small molecules for immune-mediated diseases

Pharmaceutical Business Review

Mon, 11/16/20 - 10:31 am

small molecule drugs

drug development

immune disorders

Roche ditches EGFR drug pact with C4 Therapeutics

Fierce Biotech

Fri, 11/13/20 - 12:47 pm

C4 Therapeutics

Sanofi/Alnylam’s haemophilia drug hits another safety speed-bump

Pharmaforum

Mon, 11/9/20 - 10:59 am

Roche joins the COVID-19 antiviral drug race, betting $350M on a startup

BioPharma Dive

Thu, 10/22/20 - 10:51 am

Atea Pharmaceuticals

Roche Canada Puts Five-Year Plan into Motion to Create 500 New Jobs in Ontario

BioSpace

Wed, 10/21/20 - 11:41 pm

Roche buys into Prothena... kind of

EP Vantage

Wed, 10/21/20 - 10:39 am

Parkinson's Disease

Roche drops $500M into new global manufacturing logistics hub, with 500 jobs to follow

Fierce Pharma

Tue, 10/20/20 - 10:58 am

Roche's James Sabry inks his second AI deal in back-to-back pacts — this time partnering Genentech with Stanford spinout Genesis Therapeutics

Endpoints

Mon, 10/19/20 - 11:07 pm

artificial intelligence

drug development

Genesis Therapeutics

FDA grants full approval for Roche/AbbVie’s Venclexta in AML combination therapies

Pharmaforum

Mon, 10/19/20 - 10:56 am

clinical trials

Dyno, Roche to tackle CNS, liver disease in gene therapy deal worth up to $1.8B

Fierce Biotech

Wed, 10/14/20 - 10:49 am

Spark Therapeutics

Roche to launch high-volume SARS-CoV-2 antigen test

Biopharma Reporter

Tue, 10/13/20 - 11:05 am

Emergency Use Authorization

SQZ Biotech Lines Up an IPO on the NYSE to Fund Cell Therapy R&D

Xconomy

Mon, 10/12/20 - 06:06 pm

From no drugs to 3: Patients with spinal muscular atrophy now face hard choices

BioPharma Dive

Mon, 10/5/20 - 11:39 pm

spinal muscular atrophy

Pages